Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 29/11/2020
SIETES contiene 93175 citas

 
 
 1 a 20 de 27 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Ioannidis JPA. The proposal to lower P value thresholds to .005. JAMA 2018;319:1429-30. [Ref.ID 102667]
2. Cita con resumen
Vicente Sánchez MP, Macías Saint-Gerons D, de la Fuente Honrubia C, González Bermejo D, Montero Corominas D, Catalá-López F. Evolución del uso de medicamentos ansiolíticos e hipnóticos en España durante el período 2000-2011. Rev Esp Salud Pública 2013;87:247-55. [Ref.ID 95641]
3. Cita con resumen
Ioannidis J, Karassa F. The need to consider the wider agenda in systematic reviews and meta-analyses. BMJ 2010;341:762-5. [Ref.ID 89476]
4. Cita con resumen
Pocock SJ, Ware JH. Translating statistical findings into plain English. Lancet 2009;373:1926-8. [Ref.ID 85993]
5.Enlace a cita original Cita con resumen
Carvajal A, Macías D, Salado I, Sáinz M, Ortega S, Campo C, García del Pozo J, Martín Arias LH, Velasco A, Gonçalves S, Pombal R, Carmona R. Heart rhythm disturbances associated with rupatadine: a case series from the Spanish and Portuguese pharmacovigilance systems. Clin Pharmacol Ther 2009;85:481-4. [Ref.ID 85537]
6. Cita con resumen
Schofield I. Sanofi-Aventis, Teva and Lipitor top EU 2007 rankings. Scrip 2008;3421/22:34. [Ref.ID 84793]
7. Cita con resumen
Jagger C, Gillies C, Moscone F, Cambois E, Van Oyen H, Nusselder W, Robine J-M, and the EHLEIS team. Inequalities in healthy life years in the 25 countries of the European Union in 2005: a cross-natinoal meta-regression analysis. Lancet 2008;372:2124-31. [Ref.ID 84787]
8. Cita con resumen
9. Cita con resumen
Anónimo. EMEA recommends withdrawal of veralipride. Scrip 2007;3280:3. [Ref.ID 80649]
10. Cita con resumen
Moszynski P. UK is behind other rich countries in terms of children's welfare. BMJ 2007;334:331. [Ref.ID 79341]
11.Tiene citas relacionadas Cita con resumen
Asher MI, Montefort S, Björkstén B, Lai CKW, Strachan DP, Weiland SK, Williams H, and the ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-43. [Ref.ID 77954]
12. Cita con resumen
Anónimo. Cardiovascular drugs cost Europe €28.4 billion. Scrip 2006;3137:3. [Ref.ID 76276]
13. Cita con resumen
Grimes DA, Schulz KF. An overview of clinical research: the lay of the land. Lancet 2002;359:57-61. [Ref.ID 60861]
14. Cita con resumen
Shakespeare TP, Gebski VJ, Veness MJ, Simes J. Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours. Lancet 2001;357:1349-53. [Ref.ID 56431]
15.Tiene citas relacionadas
Goodman SN. Toward evidence-based medical statistics. 1: the P value fallacy. Ann Intern Med 1999;130:995-1004. [Ref.ID 45252]
16.
Kulkarni PM, Tripathi RC, Michalek JE. Maximum (Max) and Mid-P confidence intervals and p values for the standardized mortality and incidence ratios. Am J Epidemiol 1998;147:83-6. [Ref.ID 37173]
17. Cita con resumen
18.
Matthews JNS, Altman DG. Interaction 2: compare effect sizes not P values. BMJ 1996;313:808. [Ref.ID 29266]
19.
Altman DG, Bland JM. Absence of evidence is not evidence of absence. BMJ 1995;311:485. [Ref.ID 24672]
20.
Walter SD. Methods of reporting statistical results from medical research studies. Am J Epidemiol 1995;141:896-906. [Ref.ID 24247]
Seleccionar todas
 
 1 a 20 de 27 siguiente >>